Sentry Page Protection
MMI Scenario 17
Omar, aged 64, has come in to see you this morning, for a medication review and follow up consultation, 3 months after his metformin treatment was initiated in primary care. The prescribed dose is metformin 500mg tablets 1 BD. He was recently diagnosed with Type 2 Diabetes three months ago. Before he has come into see you this morning, you have reviewed his recent bloods results and noticed that his HbA1c is now 53mmol/mol, an increase from 48 mmol/mol as his baseline. He has no other diagnosed co-morbidities, drug history or drug allergies. What is important to explore at this stage? What are the main issues you would like to discuss with Omar?